Gonabadi Nafise Sadat Alavi, Menbari Shaho, Farsiani Hadi, Sedaghat Hosein, Motallebi Mitra
Department of Immunology and Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
Department of Medical Laboratory Sciences, Faculty of Paramedical Sciences, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Heliyon. 2024 Jul 9;10(14):e34384. doi: 10.1016/j.heliyon.2024.e34384. eCollection 2024 Jul 30.
species significantly impact global health due to their role in diarrheal diseases. A 2019-2022 cross-sectional study on 432 stool samples from pediatric patients in Mashhad, Iran, identified spp. and tested their susceptibility to 12 antimicrobials by the disk diffusion method. The presence of virulence factors, namely , , , and , as well as plasmid-mediated quinolone resistance (PMQR) genes, including , , , , and , were ascertained through the utilization of polymerase chain reaction techniques. Sequencing of 15 isolates detected mutations within quinolone resistance-determining regions (QRDRs) at the and genes, indicating fluoroquinolone (FQ) resistance. 19.2 % (83/432) of stool samples contained , primarily (77.1 %), followed by (21.6 %) and (1.2 %). Most isolates were from children under five (55.4 %). All strains had the gene, lacked and , and 86.7 % had . High resistance was noted for ampicillin and tetracycline (84.3 % each), trimethoprim-sulfamethoxazole (81.9 %), and azithromycin (60.2 %). 87.1 % of isolates were multidrug-resistant (MDR). The most common PMQR genes were and (41 % each). The gene, prevalent in 36.1 % of cases, is reported in Iran for the first time. The most common PMQR profile was (15.7 %). Resistance to nalidixic acid and ciprofloxacin was 45.8 % and 12 %, respectively. The isolates exhibited mutations in the (at codons 83, 87, and 211) and (at codons 80, 84, 93, 126, 128, 129, and 132) genes. The D87Y mutation in the gene was the most common in isolates, occurring in 73 % of cases. The F93S and L132T mutations in the gene were unique to this study. Empirical FQ therapy in patients infected with MDR , possessing PMQR determinants and/or mutations in the QRDRs of and , may escalate the risks of secondary diseases, extended treatment duration, therapeutic failure, and resistance spread. Consequently, the necessity for continuous surveillance and genetic testing to detect FQ-resistant strains is of paramount importance.
由于其在腹泻疾病中的作用,[具体物种名称]对全球健康有重大影响。一项2019 - 2022年对伊朗马什哈德儿科患者的432份粪便样本进行的横断面研究,鉴定出了[具体物种名称],并通过纸片扩散法测试了它们对12种抗菌药物的敏感性。通过聚合酶链反应技术确定了毒力因子[具体毒力因子名称1]、[具体毒力因子名称2]、[具体毒力因子名称3]和[具体毒力因子名称4]的存在,以及质粒介导的喹诺酮耐药性(PMQR)基因,包括[具体PMQR基因名称1]、[具体PMQR基因名称2]、[具体PMQR基因名称3]、[具体PMQR基因名称4]和[具体PMQR基因名称5]。对15株分离株进行测序,检测到[具体基因名称1]和[具体基因名称2]的喹诺酮耐药决定区(QRDRs)内发生了突变,表明对氟喹诺酮(FQ)耐药。19.2%(83/432)的粪便样本含有[具体物种名称],主要是[具体亚种名称1](77.1%),其次是[具体亚种名称2](21.6%)和[具体亚种名称3](1.2%)。大多数分离株来自五岁以下儿童(55.4%)。所有菌株都有[具体基因名称3]基因,缺乏[具体基因名称4]和[具体基因名称5],86.7%有[具体基因名称6]。氨苄西林和四环素的耐药率较高(均为84.3%),甲氧苄啶 - 磺胺甲恶唑为81.9%,阿奇霉素为60.2%。87.1%的分离株为多重耐药(MDR)。最常见的PMQR基因是[具体PMQR基因名称1]和[具体PMQR基因名称2](各占41%)。[具体PMQR基因名称3]基因在36.1%的病例中普遍存在,这是首次在伊朗报道。最常见的PMQR谱型是[具体谱型名称](15.7%)。对萘啶酸和环丙沙星的耐药率分别为45.8%和12%。[具体物种名称]分离株在[具体基因名称1](密码子83、87和211处)和[具体基因名称2](密码子80、84、93、126、128、129和132处)基因中表现出突变。[具体基因名称1]基因中的D87Y突变在[具体物种名称]分离株中最常见,发生在73%的病例中。[具体基因名称2]基因中的F93S和L132T突变是本研究特有的。对感染了MDR [具体物种名称]、具有PMQR决定簇和/或[具体基因名称1]和[具体基因名称2]的QRDRs中发生突变的患者进行经验性FQ治疗,可能会增加继发疾病、延长治疗时间、治疗失败和耐药性传播的风险。因此,持续监测和基因检测以检测FQ耐药[具体物种名称]菌株至关重要。